These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 28199978)
1. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway. Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978 [TBL] [Abstract][Full Text] [Related]
2. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183. Sun J; Liu L; Zou H; Yu W Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis. Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway. Li J; Li Y; Meng F; Fu L; Kong C Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway. Zhang Y; Zhu M; Sun Y; Li W; Wang Y; Yu W Oncol Res; 2019 Feb; 27(3):379-387. PubMed ID: 29523222 [TBL] [Abstract][Full Text] [Related]
6. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway. Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973 [TBL] [Abstract][Full Text] [Related]
7. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway. Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044 [TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma. Lu L; Dai Z; Luo Q; Lv G Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211 [TBL] [Abstract][Full Text] [Related]
9. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma. Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway. Xia S; Ji R; Zhan W BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway. Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway. Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J Pathol Res Pract; 2019 Feb; 215(2):302-307. PubMed ID: 30527358 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway. Zhao Q; Gao S; Du Q; Liu Y Int J Mol Med; 2018 Nov; 42(5):2839-2848. PubMed ID: 30106094 [TBL] [Abstract][Full Text] [Related]
14. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer. Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871 [TBL] [Abstract][Full Text] [Related]
15. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis. Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984 [TBL] [Abstract][Full Text] [Related]
17. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway. Wang FH; Ma XJ; Xu D; Luo J Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a. Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b. Liang T; Wang Y; Wang Y; Wang Y J Cell Physiol; 2019 Nov; 234(11):19740-19749. PubMed ID: 30941768 [TBL] [Abstract][Full Text] [Related]
20. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway. Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]